Oxidative Medicine and Cellular Longevity / 2016 / Article / Tab 2 / Review Article
Chlorinated Phospholipids and Fatty Acids: (Patho)physiological Relevance, Potential Toxicity, and Analysis of Lipid Chlorohydrins Table 2 Survey of selected diseases where myeloperoxidase (MPO) presumably represents a suitable “biomarker.” The alterations of MPO concentration and/or activity are emphasized.
Disease Changes of MPO Matrix Method Ref. Arthritis Rheumatoid arthritis Increased activity/concentration SF ELISA [120 ] Increased concentration Serum ELISA [121 ] Plasma, SF ELISA [122 ] Increased activity SF NMR [123 ] Juvenile idiopathic arthritis Increased concentration Serum Serum [124 ] Plasma ELISA [125 ] Atherosclerosis Increased concentration Plasma ELISA [126 ] Mixed with lipoproteins ELISA [127 ] AP IHC; western blot [128 ] HPLC, western blot [129 ] Increased release by culprit plaque samples CP ELISA [130 ] Increased activity AP Spectrophotometry [131 ] Diabetes Increased level Serum Spectrophotometry [132 ] Increased activity at higher G allele, anti-inflammatory effect of mutant A allele MPO -463 G/A SNP PCR [133 ] Increased concentration Plasma ELISA [134 ] Decreased activity Neutrophilic cell lysate Spectrophotometry [135 ] Neurodegenerative diseases Alzheimer’s disease Increased concentration Plasma ELISA [136 ] Expression Astrocytes Confocal microscopy, IHC [137 ] Increased Expression Brain tissue Immunoblot, IHC, PCR [138 ] Parkinson’s disease Expression Brain tissue IHC [139 ] Multiple sclerosis Increased activity/concentration Cerebral Cortex Colorimetric analysis [140 ] Expression Microglia IHC [141 ] Systemic lupus erythematosus Increased concentration Serum ELISA [121 ] Plasma ELISA [142 ] Lung diseases Acute pulmonary tuberculosis Increased concentration Serum EIA [143 ] COPD Increased levels Sputum Meta-analysis [144 ] ELISA [145 , 146 ] Cystic fibrosis Increased concentration Sputum ELISA [147 ]
SF, synovial fluid; AP, atherosclerotic plaque; COPD, chronic obstructive pulmonary disease; CP, culprit plaque; EIA, Enzyme Immunoassay; ELISA, Enzyme-Linked Immunosorbent Assay; HPLC, High Performance Liquid Chromatography; IHC, immunohistochemistry; NMR, Nuclear Magnetic Resonance; SNP, Single Nucleotide Polymorphism.